If I Knew Then: Matthew H. J. Kim

If I Knew Then: Matthew H. J. Kim October 31, 2016 The Mistake: I fell in love with a technology before understanding the impact or value the technology can have in the real world. In my prior medical startup, I created a drug delivery platform which had a very novel way of delivering medication to

Save Lives With Simple Oral Cancer Screenings

Save Lives With Simple Oral Cancer Screenings October 17, 2016 According to the World Health Organization, there are more than 529,000 new cases of oral (lip, oral cavity, and pharynx) cancer each year worldwide, with mortality rates reaching up to 292,000 deaths each year.1 In the United States, more than 48,000 individuals will be diagnosed with

MoneyTree Report: Florida’s Venture Dollars on Track to Surpass 2015

MoneyTree Report: Florida’s Venture Dollars on Track to Surpass 2015 October 14, 2016 Florida’s startup and expanding companies so far this year have raised $1 billion in venture capital and angel investments, more than double 2015’s total of $459.89 million, according to a MoneyTree Report released Friday. While on track for the best year since

Vigilant Biosciences Awarded Grant for Oral Cancer Diagnostic System

Vigilant Biosciences Awarded Grant for Oral Cancer Diagnostic System October 12, 2016 Vigilant Biosciences, a developer of solutions that aid in the early detection and intervention of cancer, has received a Phase I Small Business Innovation Research grant of $219,454 from the National Institute of Dental and Craniofacial Research. The 15-month grant will fund research

Cell Biomarkers To Distinguish Deadly From Less Aggressive HPV Oral Cancers

Cell Biomarkers To Distinguish Deadly From Less Aggressive HPV Oral Cancers October 3, 2016 MedicalResearch.com interview with: Elizabeth Franzmann, M.D. Scientific Founder and Chief Scientific Officer Vigilant Biosciences MedicalResearch.com: What is the background for this study? Response: Head and neck cancer involves cancers of the oral cavity, oropharynx and larynx. It is difficult to treat.

Vigilant Biosciences Receives Funds to Develop Oral Cancer Diagnostic

Vigilant Biosciences Receives Funds to Develop Oral Cancer Diagnostic August 29, 2016 Vigilant Biosciences Inc, Fort Lauderdale, Fla, has received a Phase I Small Business Innovation Research (SBIR) grant in the amount of $219,454 from the National Institute of Dental and Craniofacial Research (NIDCR). The 15-month grant will fund research by Vigilant Biosciences to develop

Fort Lauderdale Biotech Receives Small-Business Research Grant

Fort Lauderdale Biotech Receives Small-Business Research Grant August 11, 2016 Fort Lauderdale-based Vigilant Biosciences announced Thursday it has received a Small Business Innovation Research grant for more than $200,000 from the National Institute of Dental and Craniofacial Research. The 15-month grant will finance research to develop a diagnostic test that utilizes optical imaging in combination

Head, Neck Cancer’s Global Challenge

Head, Neck Cancer’s Global Challenge July 26, 2016 Head and neck cancer is a growing challenge with more than 650,000 new cases and more than 360,000 deaths worldwide each year. Historically, the death rate associated with this cancer is particularly high due to late-stage diagnosis and intervention. More than 40 percent of those diagnosed with

Fort Lauderdale-based Vigilant Biosciences Raises $5 Million for Oral Cancer Detection Products

Fort Lauderdale-based Vigilant Biosciences Raises $5 Million for Oral Cancer Detection Products July 12, 2016 Fort Lauderdale startup Vigilant Biosciences has raised $5 million from investors, bringing its total amount raised to $12.5 million to date, the company said Monday. The money will be used for commercial development of the company’s OncAlert oral cancer detection

Life Sciences Company Taking Oral Cancer Detection Products to Market

Life Sciences Company Taking Oral Cancer Detection Products to Market July 11, 2016 Vigilant Biosciences is developing products for the early detection and intervention of cancer. On Monday, the Fort Lauderdale life sciences company announced it closed a $5 million round of financing, bringing its total amount of funding raised to date to $12.5 million. Existing

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2